 WALTHAM, Mass.--BUSINESS WIRE--EUROIMMUN, a PerkinElmer, Inc. company NYSE: PKI, announced today that the U.S. Food and Drug Administration has provided Emergency Use Authorization EUA for its Anti-SARS-CoV-2 S1 CurveTM ELISA IgG. This assay allows for the qualitative and semi-quantitative detection of IgG antibodies formed against the SARS-CoV-2 S1 antigen, in human serum and plasma. Clinical laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 CLIA can 